Here are three things to know:
1. The company designs regenerative implants for orthopedic surgery.
2. Earlier this year, BioRez raised $1.5 million in financing. It is in the process of developing a pipeline of devices for commercialization as early as 2020.
3. The company’s current programs are focused on developing a bio-inductive scaffold for anterior cruciate ligament construction that is designed to spare harvesting of patient donor tissue.
More articles on biologics:
Dr. James Bicos: Why biologics is so exciting for the future of orthopedics
Dr. Alpesh Patel: The biggest challenge in spine today + new innovations in spinal biologics
Dr. Alejandro Badia uses bioimplant to treat thumb osteoarthritis
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
